Hattie Hayes is the editor of Ophthalmology Times Europe.
ESCRS 2023: Olivier Benoit says Ciliatech’s glaucoma implant defied his expectations
In the years to come, Ciliatech will release more data around their novel Cilioscleral Interposition Device (CID)
ESCRS 2023: Talking next-generation femtosecond lasers for corneal refractive surgery with Prof Rohit Shetty
The future of refractive surgery is bright, thanks to OCTs and advances in laser technology
ESCRS 2023: Ana Neves explains the strategy behind the workflow-oriented ZEISS booth
At the meeting, ZEISS Meditec Ophthalmology showcased the VISUMAX 800 and a host of new launches
ESCRS 2023: Dr Amir Hamid praises the wide range of technologies on view
The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting
ESCRS 2023: Fritz Hengerer, MD, PhD, presents new data for cataract surgeons
The director of Frankfurt’s Bürgerhospital eye hospital shared 7 years’ data on the iStent inject®
ESCRS 2023: The three things that make this meeting a priority for Dr Sheng Lim
The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024
ESCRS 2023: New artificial intelligence integrations are ahead for iCare
The diagnostics company is using AI to screen for diabetic retinopathy, glaucoma and age-related macular degeneration
ESCRS 2023: Scott D. Barnes, MD, looks to the future of user-friendly lens injectors
New cataract and refractive options from STAAR Surgical could come as early as this year
ESCRS 2023: Device-centric focus drives a redesign at Geuder
Two members of the team gave a preview of Geuder’s 2024 spotlight products
ESCRS 2023: Data-driven innovation in the glaucoma space with Keith Barton
As part of the meeting’s MIGS programme, Keith Barton, MD, FRCP, FRCS, FRCOphth, shared data from the iTrack™ Global Data Registry
ESCRS 2023: Orbis International details new education partnership and celebrates 20 years of Cybersight
The nonprofit marked a major milestone by announcing a suite of webinars with Heidelberg Engineering
ESCRS 2023: Managing directors from Heidelberg Engineering preview Orbis partnership
The diagnostic imaging experts will provide education through the Cybersight platform
ESCRS 2023: Greg Kunst looks ahead at the next 5 years of Aurion Biotech’s cell therapies
In a conversation at ESCRS, the CEO said by 2028, Aurion Biotech hopes to see global registration for its corneal endothelial disease therapies.
Syncona announces Novartis will discontinue development of GT005 for geographic atrophy
Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022
ESCRS 2023: Thomas Bosshard discusses Oertli's 3-platform approach
At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.
ESCRS 2023: Krysten Williams talks about bringing Heidelberg image quality into the surgical theater
At the 2023 European Society Of Cataract & Refractive Surgeons (ESCRS) meeting in Vienna, Krysten Williams, head of marketing and education at Heidelberg Engineering, spoke to our team about the newest imaging advancements in the clinic and the operating room.
ESCRS 2023: Binkhorst Medal lecture addresses the future of cataract and refractive surgery
Jorge Alio, MD, PhD, FEBOpthhal spoke with our team about his Binkhorst Medal lecture topic, the future of cataract and refractive surgery, while at the 2023 ESCRS meeting in Vienna, Austria.
ESCRS 2023: Integrated workflow solutions in cataract procedures
Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.
Orbis and Heidelberg Engineering announce new partnership at ESCRS congress
The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.
Ciliatech presents clinical trial results from SAFARI III glaucoma study
The company announced new data on outcomes for both open and narrow angle glaucoma patients.
ZEISS Medical Technology previews refractive workflow innovations ahead of ESCRS annual meeting
Advancements from Carl Zeiss Medical AG in the cataract and cornea space include a new intraocular lens and therapeutic laser enhancements.
ESCRS celebrates dual milestones for EUREQUO Registry
The EUREQUO Annual Report celebrates 15 years and over 4 million surgical procedures in the registry.
EMA approves Clinical Trial Application for retinitis pigmentosa therapy from ViGeneron
VG901 is a gene therapy for CNGA1-associated RP.
EMA accepts Iveric Bio’s avacincaptad pegol (ACP) for MAA review
The geographic atrophy treatment was approved by the FDA in the US earlier this month.
Sandoz releases positive results for biosimilar aflibercept in MYLIGHT Phase III study
The study met its primary efficacy endpoint for the neovascular age-related macular degeneration (nAMD) treatment.
New glaucoma treatment development: the cilioscleral technique
FDA issues approval for Iveric Bio avacincaptad pegol intravitreal solution for treatment of geographic atrophy
IZERVAY is expected to be available in the United States within 2 to 4 weeks.
Preview: ESCRS Congress in Vienna, Austria
This year’s meeting will include boxing rings, ball gowns
and a full schedule of engaging new symposia
European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issues positive opinion for aflibercept biosimilar YESAFILI®
The Biocon Biologics, Ltd product moves on to review by the European Commission, with an expected decision in late September 2023.
Tenpoint Therapeutics launches with $70 million in funding for cell therapy platform
The London-based company will use regenerative medicine to fight ocular disease.
2 Clarke Drive Cranbury, NJ 08512